Guyasuta Investment Advisors Inc Bristol Myers Squibb CO Transaction History

Guyasuta Investment Advisors Inc

$1.51 Billion
Q3 2024

A detailed history of Guyasuta Investment Advisors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 49,451 shares of BMY stock, worth $2.91 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

49,451

Previous 49,450 -0.0%

Holding current value

$2.91 Million

Previous $2.05 Million 24.65%

% of portfolio

0.17%

Previous 0.14%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $39 - $51	1 Added 0.0%	49,451 $2.56 Million
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $3,975 - $4,743	-82 Reduced 0.17%	49,450 $2.54 Million
Q2 2023 Jul 17, 2023	BUY	$63.71 - $70.74 $8,091 - $8,983	127 Added 0.26%	49,532 $3.17 Million
Q1 2023 Apr 28, 2023	SELL	$65.71 - $74.53 $82,400 - $93,460	-1,254 Reduced 2.48%	49,405 $3.42 Million
Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $1.67 Million - $1.98 Million	24,372 Added 92.72%	50,659 $3.64 Million
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $190 - $112,877	1,469 Added 5.92%	26,287 $1.87 Million
Q2 2022 Jul 21, 2022	BUY	$72.62 - $79.98 $145 - $159	2 Added 0.01%	24,818 $1.91 Million
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $59,020 - $70,771	960 Added 4.02%	24,816 $1.81 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $728,563 - $849,334	-13,585 Reduced 36.28%	23,856 $1.49 Million
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $864,592 - $1.01 Million	14,612 Added 64.01%	37,441 $2.22 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $74,787 - $81,443	1,208 Added 5.59%	22,829 $1.53 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $15,309 - $17,218	258 Added 1.21%	21,621 $1.37 Million
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $21,763 - $25,443	397 Added 1.89%	21,363 $1.26 Million
Q1 2020 Apr 28, 2020	BUY	$46.4 - $67.43 $21,808 - $31,692	470 Added 2.29%	20,966 $1.17 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $157,422 - $205,343	3,199 Added 18.49%	20,496 $1.32 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $21,385 - $25,355	-500 Reduced 2.81%	17,297 $877,000
Q2 2019 Aug 06, 2019	SELL	$44.62 - $49.34 $69,071 - $76,378	-1,548 Reduced 8.0%	17,797 $807,000
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $102,196 - $121,857	-2,265 Reduced 10.48%	19,345 $923,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $414,460 - $537,455	-8,500 Reduced 28.23%	21,610 $1.12 Million
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $221,863 - $250,245	-4,020 Reduced 11.78%	30,110 $1.87 Million
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $75,592 - $94,218	1,496 Added 4.58%	34,130 $1.89 Million
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $216,610 - $249,362	-3,615 Reduced 9.97%	32,634 $2.06 Million
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $8,391 - $9,149	140 Added 0.39%	36,249 $2.22 Million
Q2 2017 Aug 09, 2017	BUY	N/A	36,109	36,109 $2.01 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.

Account

Guyasuta Investment Advisors Inc Bristol Myers Squibb CO Transaction History